pubrio
Voronoi Inc. logo

Voronoi Inc.

Privately Held
voronoi.io
Research200+ employeesFounded 2015🇰🇷 South Korea

VORONOI, a leading biotech in South Korea EGFR-Exon20Ins Lisenced out to ORIC Parmaceuticals in 2020 RET-Fusion Lisenced out to Inno.N in 2021 Anticipated upcoming IPO on KOSDAQ for 4Q, 2021

Founded
2015
Employees
200+
Industry
Research
Company type
Privately Held
Stock
koe: 310210.KQ
Headquarters
🇰🇷32, Songodogwahak-ro, Yeonsu-gu, It-center Bldg, Incheon, Seoul Teugbyeolsi, Kr, 21990 (+1)
Specialties
ResearchPharmaceuticalsBiotechnologyHealthcare

Expansion Intelligence

NEW · only on Pubrio

We're tracking Voronoi Inc.'s market expansion

Global expansion

Live
Stages
ExploringInvestingLandingOperating
Good to know

Frequently Asked Questions Regarding Voronoi Inc.

Quick answers about Voronoi Inc.'s business, markets, and growth signals.

VORONOI, a leading biotech in South Korea EGFR-Exon20Ins Lisenced out to ORIC Parmaceuticals in 2020 RET-Fusion Lisenced out to Inno.N in 2021 Anticipated upcoming IPO on KOSDAQ for 4Q, 2021

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

Start Journey Image
pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​

© 2026 Pubrio. All rights reserved.